BK vs. PFE
Compare and contrast key facts about The Bank of New York Mellon Corporation (BK) and Pfizer Inc. (PFE).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: BK or PFE.
Performance
BK vs. PFE - Performance Comparison
Returns By Period
In the year-to-date period, BK achieves a 55.95% return, which is significantly higher than PFE's -7.38% return. Over the past 10 years, BK has outperformed PFE with an annualized return of 9.76%, while PFE has yielded a comparatively lower 2.68% annualized return.
BK
55.95%
3.91%
37.09%
71.91%
13.57%
9.76%
PFE
-7.38%
-11.51%
-9.79%
-12.05%
-3.04%
2.68%
Fundamentals
BK | PFE | |
---|---|---|
Market Cap | $57.35B | $141.33B |
EPS | $4.47 | $0.75 |
PE Ratio | 17.65 | 33.25 |
PEG Ratio | 0.71 | 0.18 |
Total Revenue (TTM) | $17.95B | $60.11B |
Gross Profit (TTM) | $17.86B | $36.84B |
EBITDA (TTM) | $6.74B | $13.84B |
Key characteristics
BK | PFE | |
---|---|---|
Sharpe Ratio | 4.18 | -0.49 |
Sortino Ratio | 5.40 | -0.56 |
Omega Ratio | 1.72 | 0.93 |
Calmar Ratio | 3.39 | -0.22 |
Martin Ratio | 42.42 | -1.42 |
Ulcer Index | 1.72% | 8.46% |
Daily Std Dev | 17.45% | 24.47% |
Max Drawdown | -72.42% | -54.82% |
Current Drawdown | 0.00% | -53.01% |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Correlation
The correlation between BK and PFE is 0.32, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Risk-Adjusted Performance
BK vs. PFE - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for The Bank of New York Mellon Corporation (BK) and Pfizer Inc. (PFE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
BK vs. PFE - Dividend Comparison
BK's dividend yield for the trailing twelve months is around 2.26%, less than PFE's 6.69% yield.
TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
The Bank of New York Mellon Corporation | 2.26% | 3.04% | 3.12% | 2.24% | 2.92% | 2.34% | 2.21% | 1.60% | 1.52% | 1.65% | 1.63% | 1.66% |
Pfizer Inc. | 6.69% | 5.70% | 3.12% | 2.64% | 3.92% | 3.68% | 3.12% | 3.54% | 3.70% | 3.48% | 3.34% | 3.14% |
Drawdowns
BK vs. PFE - Drawdown Comparison
The maximum BK drawdown since its inception was -72.42%, which is greater than PFE's maximum drawdown of -54.82%. Use the drawdown chart below to compare losses from any high point for BK and PFE. For additional features, visit the drawdowns tool.
Volatility
BK vs. PFE - Volatility Comparison
The current volatility for The Bank of New York Mellon Corporation (BK) is 5.41%, while Pfizer Inc. (PFE) has a volatility of 7.04%. This indicates that BK experiences smaller price fluctuations and is considered to be less risky than PFE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
BK vs. PFE - Financials Comparison
This section allows you to compare key financial metrics between The Bank of New York Mellon Corporation and Pfizer Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities